UK-based Airedale Chemical has promoted a manager to procurement director, joining the five strong board of directors at the family owned firm. Tony Howell, who joined the chemical manufacturer in 2010 and worked in sales prior to launching the procurement department in 2015 to help re-structure the business, has joined the board to further […]
Post Type Archives: News
Axalta unveils StarLite as 2018 automotive colour of the year
Axalta Coating Systems has announced the release of StarLite, its 2018 Automotive Colour of the Year. StarLite is a modern, technology-savvy, premium colour for vehicles of today and tomorrow. Borne from Axalta’s ChromaDyne line of colour coats developed for automotive OEMs, StarLite is a light and reflective hue that uses Axalta’s tri-coat process which is […]
Air Products to acquire Shell’s Coal Gasification Technology business
Air Products has announced an agreement to acquire Royal Dutch Shell plc’s (Shell’s) Coal Gasification Technology business as well as Shell’s patent portfolio for Liquids (Residue) Gasification. Financial terms are not being disclosed, and the acquisition is expected to close in the coming months. “The acquisition of Shell’s technology, already in operation at more than […]
Successful consortium for powder processing
The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, has announced that the three-year project ‘Chariot’, an £18 million consortium set up to drive the commercialisation for new and improved powder-based consumer products, has successfully finished. The project, funded by the Advanced Manufacturing Supply Chain Initiative, has delivered and demonstrated multiple […]
Croda acquires marine biotechnology specialists
Croda International Plc, who create, make and sell speciality chemicals for some of the biggest, most successful brands in the world, today announced that it has acquired Nautilus Biosciences Canada Inc (‘Nautilus’), a technology-rich marine biotechnology company based in Charlottetown, Prince Edward Island, Canada. Nautilus was founded in 2007 by Professor Russell Kerr and, […]
Syngenta petitions US EPA for expanded use of neonicotinoid thiamethoxam
Syngenta has petitioned the U.S. Environmental Protection Agency for expanded uses of its neonicotinoid insecticide thiamethoxam. Most of the new uses are on already-registered crops that are considered “unattractive” to pollinators. Others are attractive “only under certain conditions,” where any potential risk can be mitigated. Farmers are in critical need of additional insect pest […]
AkzoNobel and Gasunie looking to convert water into green hydrogen using sustainable electricity
AkzoNobel Specialty Chemicals and Gasunie New Energy have joined forces to investigate the possible large scale conversion of sustainable electricity into green hydrogen via the electrolysis of water. Intended for Delfzijl in the Netherlands, the installation would use a 20 megawatt water electrolysis unit, the largest in Europe, to convert sustainably produced electricity into 3,000 […]
AkzoNobel announces 2018 Imagine Chemistry challenges
AkzoNobel Specialty Chemicals has announced the challenges for its latest Imagine Chemistry program, which has fast become a key element of the company’s collaborative innovation approach. First launched to great success in 2017, Imagine Chemistry is an opportunity for startup and scale-up firms and researchers to solve real industry challenges and create sustainable business opportunities […]
AMRI names new CEO
AMRI, a contract research, development, and manufacturing organization, has appointed Michael Mulhern as chief executive officer, succeeding William S. Marth. Marth will remain with the company in an advisory role. Mulhern was previously chief executive officer of Sterigenics International, an Oak Brook, Illinois-headquartered provider of contract sterilization, gamma technologies, and medical isotopes. AMRI is a […]
Sanofi and Regeneron boost investment in immunotherapies
Sanofi and Regeneron are boosting their investment in development programmes for the PD-1 antibody cemiplimab in oncology and dupilumab in Type 2 (tissue specific) allergic diseases by around $1 billion more than the sum originally agreed by the two companies in 2015. The total investmen will now amount to $1.64 billion, asSanofi and Regeneron continue […]